Navigation Links
immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
Date:9/21/2010

mpany developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates. In particular, it allows the company to perform a Phase III pivotal trial of its lead product IMA901 which in data reported in June at ASCO, demonstrated the potential to confer an overall survival benefit in patients with advanced renal cell carcinoma (RCC).

The Series C round was supported by both existing and new investors. Approximately half of the funds came from dievini Hopp Biotech holding, Wellington Partners and other existing shareholders, the other half coming from new investors MIG-advised funds and AT Impf GmbH. Upon the completion of the round Dr. Matthias Kromayer from MIG AG will join the immatics board. dievini Hopp BioTech holding remains immatics' largest shareholder following this financing.

With the new funds, immatics will start a Phase III pivotal clinical trial with its lead cancer vaccine IMA901 later this year. IMA901 is a rationally designed cancer vaccine comprised of 10 different tumor-associated peptides (TUMAPs) that are frequently found to be over-expressed in the majority of patients suffering from renal cell carcinoma. The trial design builds on insights gained from the Phase II study and input from key opinion leaders and regulatory agencies. The trial will be a randomized, controlled study that will evaluate IMA901 in renal cell carcinoma patients in combination with standard of care against standard of care alone in a first-line setting. The primary end point of the trial will be overall survival and the first results are expected towards the end of 2013.

immatics will also continue the clinical development of IMA910, another therapeutic vaccine that is currently being evaluated in a Phase II clini
'/>"/>

SOURCE immatics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Dyadic International Raises Additional $1 Million to Complete $4 Million Convertible Note Offering
2. StatRad Raises the Bar With Fully Integrated Teleradiology Solution
3. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
4. AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides
5. Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
6. SynapDx Corporation Raises $9 Million in Series A Funding
7. NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device
8. Curexo Technology Corporation Raises $13.2 Million
9. Cardinal Health Raises Quarterly Dividend By 11 Percent
10. IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment
11. Intercept Pharmaceuticals Raises $25 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  Arena Pharmaceuticals, Inc. ... provide a corporate update and report second quarter 2014 ... on Friday, August 1, 2014. That same day, Arena ... a.m. Eastern Time (5:30 a.m. Pacific Time). ... 877.643.7155 for domestic callers and 914.495.8552 for international callers. ...
(Date:7/24/2014)... Kan. , July 24, 2014  Parnell ... two compounds that will be added to Parnell,s ... Australian-based CIMTECH Pty Ltd, a biotechnology company. The ... 122 have shown promise in bone regeneration and ... to develop the compounds for the veterinary market ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Reportlinker.com announces that a new market research ... Levosimendan - Comprehensive patent search ... unnecessary risk with the industry benchmark in comprehensive ... regularly updated, professional patent search performed by our ...
... 20, 2011 Sagent Pharmaceuticals (Nasdaq: SGNT ) ...  The size of the offering has been increased from the ... of common stock at a price to the public of ... on The NASDAQ Global Market on April 20, 2011 under ...
Cached Medicine Technology:Reportlinker Adds Levosimendan - Comprehensive patent search 2Reportlinker Adds Levosimendan - Comprehensive patent search 3Reportlinker Adds Levosimendan - Comprehensive patent search 4Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering 2
(Date:7/28/2014)... Building a sense of neighborhood and outdoor ... personal outdoor space is not possible, building a park ... exercise outside is important. That’s why Old Buckingham ... playground equipment from APCPLAY. , Old Buckingham Station is ... is an historic tourist location of one of the ...
(Date:7/28/2014)... In The Tainted Burger ... to a disadvantaged consumer base, be it ... often offensive, ethnically-slanted advertisements to bombard the ... Burger." Amazon: http://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Daps&field-keywords=tainted%20burger .) , ... and activist who says, "So what I ...
(Date:7/27/2014)... 2014 Manufacturers of natural ingredient beauty ... to achieve a younger appearance. The Cherry News company ... help men and women explore the availabilities from U.S. ... are presented in the posted guide on the Cherry ... consumers. On drawback to some natural ingredient formulas is ...
(Date:7/27/2014)... CA (PRWEB) July 27, 2014 Ticket Down ... Tickets at The Forum in Inglewood, California on November 15th. ... and diehard fans can expect to hear songs from this amazing ... of Summer concert in Inglewood, California at The Forum will be ... starting at 10:00 a.m. today local time TicketDown.com. This popular ...
(Date:7/27/2014)... The constant expansion of companies across the globe has ... Additional factors that have increased this demand include the ... communication, learning and development, security and safety, and knowledge ... enterprise video market value has crossed $11.21 billion in ... 2018 with a compound annual growth rate (CAGR) of ...
Breaking Medicine News(10 mins):Health News:Playground Creates Outdoor Fun for Community at Old Buckingham Station at Midlothian Village (VA) with APCPLAY© 2Health News:The Tainted Burger- McDonalds's Franchise Owner's Tale by Author Michael B. Potts Says McDonald's Disproportionately Markets to Minorities--Tedx Video Supports Claim 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4
... to Defend His TitleNORTHRIDGE, Calif., March 3 There ... names, two decks of shuffled playing cards, or a ... minutes. Chester Santos, the 2008 USA National Memory Champion, ... when he defends his title at the USA National ...
... to Raise One Million Dollars for Charity, Makes a Request ... At 56, Linda Quirk has undergone an amazing journey ... year. She began her trek across the globe by ... gone on to run the Great Wall of China, Easter ...
... reported that aspirin inhibited the growth of H. ... the activity of virulence factors of H. pylori ... H. pylori to antimicrlbials including metronidazole, clarithromycin and ... team led by Prof. Wang from Peking University First ...
... of unknown etiology that is characterized by the presence ... the past few years, the understanding of this disease ... genetically predisposed individual, certain agents such as drugs and ... , Dr. Waleed K Al-Hamoudi from Saudi Arabia ...
... March 3 Humana (NYSE: HUM ) has,recently released ... The Stay Smart, Stay Healthy videos have ... were launched on November 5, 2008, and remained,in the Top 5 ... topics in a fun and simple format. , ...
... the DNC bolsters firm,s national government affairs practiceWASHINGTON, ... nationally recognized political figure, presidential candidate and six ... an independent consultant exclusive to the government affairs ... Governor Dean will provide guidance to clients, particularly ...
Cached Medicine News:Health News:The Making of a Memory Champion 2Health News:The Making of a Memory Champion 3Health News:56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year 2Health News:56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year 3Health News:Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials? 2Health News:Varicella zoster infection causes severe autoimmune hepatitis 2Health News:Humana Releases Stay Smart, Stay Healthy Videos in Spanish 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 3
... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...
... The Universal Biomedical Amplifier (UBA-4204) ... true DC signal amplification and ... commonly seen amplifier problems of ... saturation. These features make the ...
The STALIF stand-alone anterior lumbar fusion cage is the latest product development from Surgicraft. STALIF is the natural evolution of the Hartshill Horseshoe, which has over 10 years clinical suc...
... PACHETTE 3 will enable eye care professionals ... utilizing improved ultrasound technology. The PACHETT 3 ... algorithm used in all the DGH pachymeters ... DGH Model 555 PACHETTE 3 is capable ...
Medicine Products: